Latest Operational Outlook News

Tyranna Resources has advanced its exploration and acquisition efforts in Angola, securing a major stake in the Chinguar Gold Project and extending its lithium-caesium project tenure, supported by a solid cash position.

Dimerix Limited reports solid progress in its Phase 3 trial for DMX-200 targeting rare kidney disease FSGS, backed by orphan drug status in Japan and a robust cash position. The company prepares to engage the FDA on new data supporting regulatory approval.

Macro Metals Limited has bolstered its financial position with a $2 million capital raise while making significant progress across its iron ore and construction sand projects, underpinned by strong Indigenous joint ventures and mining services development.

Assetora Limited disclosed a $341,000 net operating cash outflow for the September 2025 quarter, supported by $1.6 million in total available funding including cash reserves and financing facilities.

Diatreme Resources reported progress on its Northern Silica Project with key regulatory approvals and metallurgical successes, while agreeing to sell its Clermont Copper/Gold Project to Moonlight Resources, retaining a significant stake.

E79 Gold Mines Limited reported a net cash outflow of AUD 827,000 for the September 2025 quarter but bolstered its financial position through a successful capital raising in October. The company plans to reduce exploration expenditure in the coming quarter while maintaining operational continuity.

Sheffield Resources has locked in a zircon concentrate offtake deal with Yansteel, stabilising revenue amid challenging market conditions in China and reinforcing partnership commitments at the Thunderbird mine.

Brazilian Critical Minerals Limited reported a net cash outflow of AUD 1.2 million for Q3 2025, offset by strong financing inflows that boosted its cash reserves to AUD 2.46 million. The company’s extended loan facility and available credit provide a runway of over five quarters at current spending levels.

Reward Minerals has acquired a key exploration licence covering the Beyondie Potash Plant and is progressing its proprietary potash processing technologies alongside new copper and gold exploration initiatives.

PYC Therapeutics has reported significant progress across its four RNA therapeutic programs targeting genetic diseases, alongside a strong cash runway supporting ongoing development.

Orion Minerals reported a net cash outflow of A$3.1 million for the September 2025 quarter but has secured an $8.6 million capital raise post-quarter to support ongoing project development and operations.

Kaiser Reef Limited has announced a significant 29% increase in Ore Reserves at its Henty Gold Mine in Tasmania, extending mine life beyond six years and targeting annual production above 30,000 ounces of gold.